Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
fluoxetine | neuronal acetylcholine receptor subunit alpha-2 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | antagonist |
fluoxetine | neuronal acetylcholine receptor subunit alpha-2 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | antagonist |
fluoxetine | neuronal acetylcholine receptor subunit alpha-3 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | antagonist |
fluoxetine | neuronal acetylcholine receptor subunit alpha-3 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | antagonist |
fluoxetine | neuronal acetylcholine receptor subunit beta-4 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | antagonist |
fluoxetine | neuronal acetylcholine receptor subunit beta-4 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | antagonist |
fluoxetine | cyclin-dependent kinases regulatory subunit 1 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | unknown |
fluoxetine | cyclin-dependent kinases regulatory subunit 1 | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | unknown |
fluoxetine | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | antagonist |
fluoxetine | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,vet_approved | antagonist |
fluoxetine | potassium voltage-gated channel subfamily h member 2 | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.02 | approved,vet_approved | inhibitor |
fluoxetine | potassium voltage-gated channel subfamily h member 2 | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.02 | approved,vet_approved | inhibitor |
fluoxetine | sodium-dependent serotonin transporter | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.43 | approved,vet_approved | inhibitor |
fluoxetine | serotonin transporter | NA | Successful target | TTD , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.43 | approved | unknown |
fluoxetine | sodium-dependent serotonin transporter | small molecule | NA | drugbank , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.43 | approved,vet_approved | inhibitor |
fluoxetine | serotonin transporter | NA | Successful target | TTD , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.43 | approved | inhibitor |
fluoxetine | serotonin transporter | NA | Successful target | TTD , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.43 | approved | inhibitor |
fluoxetine | serotonin transporter | NA | Successful target | TTD , DGIDB | Major Depressive Disorder[MeSHID:D003865] Bipolar Disorder[MeSHID:D001714] Depressive disorder[MeSHID:D003866] Maintenance[MeSHID:D008283] Bulimia Nervosa[MeSHID:D052018] Obsessive-Compulsive Disorder[MeSHID:D009771] Obsessive compulsive behavior[MeSHID:D003192] Panic Disorder[MeSHID:D016584] Depressive Disorder Treatment-Resistant[MeSHID:D061218] Mental Depression[MeSHID:D003863] Agoraphobia[MeSHID:D000379] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.43 | approved | unknown |
click here to return to the previous page |